Nabta Health is a hybrid healthcare platform that enables the accelerated detection, diagnosis and treatment of chronic diseases in women in emerging markets. By combining the best of digital and traditional healthcare along clinical pathways, we empower women in the Middle East, Africa, and South Asia to detect, diagnose, and treat chronic diseases from home, in the context of specific health goals, and in an affordable and accessible manner. Our first hybrid clinical pathway for Polycystic Ovary Syndrome (PCOS), gets women to an accurate diagnosis in 3 months versus the global average of 2.5 years. PCOS is responsible for 70% of female infertility worldwide, and is mostly (70%) misdiagnosed or undiagnosed. Our research pipeline is focused on the development of hybrid clinical pathways for other female chronic diseases such as gestational diabetes, endometriosis, hyperprolactinemia, hypothyroidism, and others. Follow us @NabtaHealth on Facebook, Instagram and Twitter.